Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Canada Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20054
20061
20073
20082
20107
20114
20125
20132
20178
20185
20195
20205
20215
20224
20238
20246
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting14
Active, not recruiting11
Terminated8
Unknown status8
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Bristol-Myers Squibb6
GlaxoSmithKline5
Novartis Pharmaceuticals5
University Health Network, Toronto5
McGill University Health Centre/Research Institute of the McGill University Health Centre4
UCB Pharma4
Biogen3
Human Genome Sciences Inc., a GSK Company3
MedImmune LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic89
Autoimmune Diseases13
Lupus Nephritis12
Arthritis, Rheumatoid6
Scleroderma, Systemic6
Immune System Diseases5
Connective Tissue Diseases4
Dermatomyositis3
Lupus Erythematosus, Cutaneous3
Lupus Erythematosus, Discoid3

Trials

Showing 51 to 75 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.